Concepedia

David-Erick Lafontant

DL

8

Publications

1.2K

Citations

8

H-Index

2009

Active since

Affiliations

University of Iowa(Current)

University of Pennsylvania

Massachusetts General Hospital

Northwestern University

University of Miami

David-Erick Lafontant is an author at University of Iowa specializing in medicine, neurodegenerative diseases, and neurology.

ORCID

Top concepts

Publications per year

2009–2023

8

Publications

8

Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study

Andrew Siderowf, Luis Concha‐Marambio, David-Erick Lafontant et al. · The Lancet Neurology · 2023 · 618 citations · Full text

, , +4

National Institutes of Health–Sponsored Clinical Islet Transplantation Consortium Phase 3 Trial: Manufacture of a Complex Cellular Product at Eight Processing Facilities

Camillo Ricordi, Julia Goldstein, Appakalai N. Balamurugan et al. · Diabetes · 2016 · 191 citations · Full text

Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson Disease

Tanya Simuni, Brian Fiske, Kalpana Merchant et al. · JAMA Neurology · 2020 · 133 citations · Full text

Improved Health-Related Quality of Life in a Phase 3 Islet Transplantation Trial in Type 1 Diabetes Complicated by Severe Hypoglycemia

Eric D. Foster, Nancy D. Bridges, Irene D. Feurer et al. · Diabetes Care · 2018 · 116 citations · Full text

Updated Percentiles for the University of Pennsylvania Smell Identification Test in Adults 50 Years of Age and Older

Michael C. Brumm, Kerri A. Pierz, David-Erick Lafontant et al. · Neurology · 2023 · 61 citations · Full text

Rows per page

1–5 of 8